openPR Logo
Press release

Revenue Growth of the HER2-Positive Breast Cancer Market to be Influenced by Growing End-use Adoption 2023-2031

12-27-2023 07:08 PM CET | Health & Medicine

Press release from: Global Insight Services

Revenue Growth of the HER2-Positive Breast Cancer Market to be

The HER2-Positive Breast Cancer Market is a crucial segment of the broader oncology pharmaceutical industry, focused on addressing a specific type of breast cancer characterized by overexpression of the human epidermal growth factor receptor 2 (HER2). HER2-positive breast cancer is an aggressive subtype, accounting for about 20-25% of all breast cancer cases. The market for HER2-positive breast cancer treatments has witnessed significant advancements in recent years, primarily driven by the development of targeted therapies like Herceptin (trastuzumab) and other monoclonal antibodies, as well as small molecule inhibitors such as lapatinib and pertuzumab. These therapies have revolutionized the treatment landscape for HER2-positive breast cancer, improving patient outcomes and reducing the risk of recurrence.

Request for Free Sample @ https://www.globalinsightservices.com/request-sample/GIS26121/?utm_source=sidram&utm_medium=openpr&utm_campaign=27122023

As the understanding of HER2-positive breast cancer's molecular underpinnings continues to evolve, the market is poised for further growth. The introduction of novel therapies, combination regimens, and immunotherapies, as well as the ongoing efforts to identify potential biomarkers and patient-specific treatment approaches, are expected to shape the market's future. Additionally, the growing prevalence of breast cancer worldwide and the increased awareness about the importance of early detection are likely to drive market expansion. Despite the remarkable progress in HER2-positive breast cancer treatment, research and innovation remain critical to improving patient outcomes and reducing the overall burden of this aggressive cancer subtype.

Key Trends

Key trends in the HER2-Positive Breast Cancer Market include the ongoing development of innovative targeted therapies and immunotherapies that aim to enhance treatment efficacy and reduce side effects, as well as the exploration of combination treatment strategies to address resistance and improve long-term outcomes for patients. Furthermore, there is a growing emphasis on precision medicine, with efforts to identify specific biomarkers and subtypes within HER2-positive breast cancer that can guide more personalized treatment decisions. Another notable trend is the increasing use of real-world data and artificial intelligence for clinical research, enabling better understanding of treatment responses and long-term patient outcomes.

Read Full Research Report @ https://www.globalinsightservices.com/reports/her2-positive-breast-cancer-market//?utm_source=sidram&utm_medium=openpr&utm_campaign=27122023

Key Drivers

Several key drivers fuel the HER2-Positive Breast Cancer Market's growth and development. Firstly, the rising incidence of breast cancer, along with the increasing recognition of HER2-positive breast cancer subtypes, is expanding the patient pool in need of targeted therapies, driving market demand. The continued evolution of precision medicine and molecular diagnostics is enabling more accurate identification of HER2-positive patients, leading to tailored treatment approaches and improved patient outcomes. Additionally, ongoing research and development efforts are resulting in the approval of novel therapies and combination regimens, providing healthcare providers with a wider range of options to manage the disease.

Buy Now@ https://www.globalinsightservices.com/checkout/single_user/GIS26121/?utm_source=sidram&utm_medium=openpr&utm_campaign=27122023

Market Segmentation : HER2-Positive Breast Cancer Market

HER2-Positive Breast Cancer Market By Treatment Type : Chemotherapy, Targeted Therapy, Immunotherapy, Others

HER2-Positive Breast Cancer Market By Route of Administration : Oral, Parenteral, Others

HER2-Positive Breast Cancer Market By End-Users : Hospitals, Homecare, Specialty Centres, Others

HER2-Positive Breast Cancer Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa

Key Players

Johnson & Johnson Private Limited (U.S.)
Cipla Inc. (U.S.)
Abbott (U.S.)
AbbVie Inc. (U.S.)
Merck KGaA (Germany)
Sun Pharmaceutical Industries Ltd. (India)
Aurobindo Pharma (India
Lupin (India)
Hikma Pharmaceuticals PLC (U.K.)
Amneal Pharmaceuticals LLC. (U.S.)
Pfizer Inc (U.S.)

Request for Customization @ https://www.globalinsightservices.com/checkout/single_user/GIS26121/?utm_source=sidram&utm_medium=openpr&utm_campaign=27122023

With Global Insight Services, you receive :

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

About Global Insight Services :

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us :

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Revenue Growth of the HER2-Positive Breast Cancer Market to be Influenced by Growing End-use Adoption 2023-2031 here

News-ID: 3339228 • Views:

More Releases from Global Insight Services

U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 to 2033
U.S. and Colorado RTD Cocktail Market Overview by Rising Demands and Scope 2024 …
Market Definition An RTD cocktail is a pre-mixed alcoholic beverage that is typically sold in a can or bottle. RTD cocktails are convenient because they require no additional mixing or preparation, making them ideal for parties or other events where alcohol will be served. There are a variety of RTD cocktails available, including popular options such as Moscow Mules, Margaritas, and Bloody Marys. RTD cocktails are typically made with lower-quality alcohol,
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Forecast 2033
Space Semiconductor Market Booming Across the Globe by Growth, Segments and Fore …
Market Definition A space semiconductor is a type of semiconductor device that is designed to function in extreme conditions found in outer space. Space semiconductors must be able to withstand high levels of radiation and extreme temperatures, as well as the vacuum of space. Space semiconductors are used in a variety of space-based applications, including satellites, spacecraft, and telescopes. They are also used in space exploration missions, such as the Mars
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Mühlbauer Group, Primekey Solutions Ab, Thales Group, Safran
E-passport Market A Deep Dive Into Market Size, Share, And Trends By 2033 | Müh …
Market Definition The E-passport Market represents a transformative shift in travel documentation, offering enhanced security and efficiency compared to traditional passports. Also known as biometric passports, E-passports incorporate a microprocessor chip containing the holder's biometric information, such as fingerprints and facial recognition data, along with personal details. This technology not only mitigates the risk of identity theft and fraud but also expedites border control processes by enabling automated authentication. Market Outlook The E-passport
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research Study, Trends, Development Status, Opportunities, Future Plans, Competitive Landscape And Growth By Forecast 2033
Oligonucleotide Synthesis Market Share, Size 2024 Global Comprehensive Research …
Market Definition The Oligonucleotide Synthesis Market is a vital component in the biotechnology and pharmaceutical industries, providing customized strands of DNA or RNA sequences for various applications such as genetic research, diagnostics, and therapeutic development. This market encompasses a range of synthesis technologies, including solid-phase synthesis and enzymatic methods, allowing researchers to tailor oligonucleotides with precision. As advancements in genomics, personalized medicine, and synthetic biology drive demand for high-quality oligonucleotides, the

All 5 Releases


More Releases for HER2

HER2 negative Breast Cancer Pipeline involves 85+ key companies continuously wor …
DelveInsight's HER2 negative Breast Cancer Pipeline Insight 2022 report offers exhaustive global coverage of available, marketed, and pipeline therapies in different phases of clinical development, major pharmaceutical companies working to advance the pipeline space, and future growth potential of the HER2 negative Breast Cancer pipeline domain. Some of the essential takeaways from the HER2 negative Breast Cancer Pipeline report: • DelveInsight's HER2 negative Breast Cancer Pipeline analysis depicts a robust space with
HER2 Antibodies Market Expand with Significant CAGR During 2018-2025
Global HER2 Antibodies Market: Overview Among all the chronic diseases worldwide cancer is considered to be the most prevalent disease. Approximately 1,685,210 new cancer cases were diagnosed and about 595,690 cancer deaths in the US in year 2016. Whereas around 2,600 men and 246,660 that is about 29% women were diagnosed with breast cancer in year 2016. HER2 breast cancer is one of the aggressive type of breast cancer, caused due
HER2 Antibodies Market to approach US$ 21,669.1 mn by 2025
A recent market intelligence study by Transparency Market Research (TMR) suggests that the global HER2 antibodies market offers lucrative opportunities as the awareness regarding breast cancer and personalized medicines spreads. Consequently, the competitive landscape of the HER2 antibodies market is already quite intense with the presence of a large number of players, both global and regional. The report identifies Pfizer, Inc., Novartis AG, Genentech Inc. by F. Hoffmann-La Roche Ltd.,
HER2 Antibodies Market Key Trends and Forecast Research Report 2025
As per the projections of the TMR report, the demand in the global HER2 antibodies market will multiply at an impressive CAGR of 8.6% during the forecast period of 2017 to 2025, achieving an estimated global valuation of US$21,669.1 mn by the end of 2025, substantially up from its evaluated worth of US$10,087.8 mn in 2016. In the near future, new drug development is expected to be based on adjuvant
HER2 Antibodies Market Key Trends and Forecast Research Report 2025
As per the projections of the TMR report, the demand in the global HER2 antibodies market will multiply at an impressive CAGR of 8.6% during the forecast period of 2017 to 2025, achieving an estimated global valuation of US$21,669.1 mn by the end of 2025, substantially up from its evaluated worth of US$10,087.8 mn in 2016. In the near future, new drug development is expected to be based on adjuvant
Her2 Antibodies Market: Industry Overview and Key Factors
Global Her2 Antibodies Market: Overview Human epidermal growth factor receptor 2 (Her2) refers to an oncogene whose over-expression or amplification is commonly associated with the development of an aggressive type of breast cancer. Patients having the over-expression of Her2 receptors are diagnosed with the help of tests such as Fluorescent In-Situ Hybridization (FISH) and Immunohistochemistry (IHC). The American Cancer Society states that around 15-30% of breast cancer cases over-express the Her2